Skip to main content

Table 1 Distribution of the questionings about further specific therapies among the different centres

From: Is shared decision-making vanishing at the end-of-life? A descriptive and qualitative study of advanced cancer patients’ involvement in specific therapies decision-making

Investigation centre

Speciality

Number of beds

Frequency of the QST: nb of included patients/nb of hospitalized patients during the inclusion period (%)

Nb of patients interviewed

Conventional

Ambulatorya

Total

Conventional

Ambulatorya

Total

University Hospital

Haematology

39

14

53

4 / 41 (9.7)

1 / 99 (1)

5 / 140 (3.5)

5

Cancer centre

Medical Oncology

46

52

98

3 / 62 (4.8)

0 / 247 (0)

3 / 309 (0.9)

1

University Hospital

Medical Oncology

23

27

50

7 / 38 (18.4)

1 / 136 (0.7)

8 / 174 (4.5)

5

Private clinic

Medical Oncology-RT

31

19

50

6 / 28 (21.4)

0 / 22 (0)

6 / 50 (12)

5

General Hospital

Onco-haematology

23

35

58

6 / 33 (18.2)

1 / 133 (0.7)

7 / 166 (4.2)

5

 

162

141

303

26 / 202 (12.8)

3 / 637 (0.4)

29 / 839 (3.4)

21

  1. QST questioning about specific therapies, nb number, RT radiotherapy
  2. aAmbulatory includes day and week hospitalization